Trial description
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment
Contact name
Dr Helen Hatcher
Trial start date
Friday, March 11, 2016
Trial end date
Monday, December 30, 2019
Trial tumour type
Show on Radiotherapy